FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Vical

Sort
E.g., 2013-05-21
E.g., 2013-05-21
Enter a comma separated list of user names.

Vical Incorporated (NASDAQ:VICL) researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases. Vical Incorporated witnessed volume of 6.87 million shares during last trade however it holds an average trading capacity of 1.05 million shares.

** Vical Inc. (VICL) and Astellas Pharma Inc. have signed exclusive license agreements to develop and commercialize globally TransVax, VICL's therapeutic vaccine designed to control cytomegalovirus reactivation in transplant recipients.

VICL potentially may receive up to $130 million in total upfront and milestone payments through commercial launch and double-digit royalties on net sales.

Hansen Medical, Inc. (NASDAQ:HNSN), the global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced that it will release its financial and operating results for the fourth quarter and full year ended December 31, 2010 after market close on Wednesday, February 23, 2011.

Pages

ADVERTISE WITH US